Business
Press Release Mar 11 2024
Wockhardt Limited has informed the Exchange regarding a press release dated March 11, 2024, titled "A leading European Journal reports achallenging Clinical Case of Successful use of under-trial drug Zidebactam/Cefepime (WCK5222, ZaynichTM) to Treat Skull Bone Infection & Pneumonia caused by Extreme-drugResistant Pseudomonas in Renal Transplant Patient".
About this update from Wockhardt Limited
[{"type":"text","content":" Wockhardt Limited has informed the Exchange regarding a press release dated March 11, 2024, titled \"A leading European Journal reports achallenging Clinical Case of Successful use of under-trial drug Zidebactam/Cefepime (WCK5222, ZaynichTM) to Treat Skull Bone Infection & Pneumonia caused by Extreme-drugResistant Pseudomonas in Renal Transplant Patient\". View Attachment","length":511,"tagName":"div"}]